310 related articles for article (PubMed ID: 36143915)
21. Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug.
Saengboonmee C; Sanlung T; Wongkham S
Anticancer Res; 2021 Dec; 41(12):5913-5918. PubMed ID: 34848445
[TBL] [Abstract][Full Text] [Related]
22. Statins as Anticancer Agents in the Era of Precision Medicine.
Longo J; van Leeuwen JE; Elbaz M; Branchard E; Penn LZ
Clin Cancer Res; 2020 Nov; 26(22):5791-5800. PubMed ID: 32887721
[TBL] [Abstract][Full Text] [Related]
23. Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review.
Ahn HK; Lee YH; Koo KC
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198356
[TBL] [Abstract][Full Text] [Related]
24. Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?
Martin M; Marais R
J Clin Oncol; 2012 Jul; 30(21):2698-700. PubMed ID: 22565000
[No Abstract] [Full Text] [Related]
25. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
26. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.
Kong AP; Yang X; So WY; Luk A; Ma RC; Ozaki R; Cheung KK; Lee HM; Yu L; Xu G; Chow CC; Chan JC
BMC Med; 2014 May; 12():76. PubMed ID: 24886453
[TBL] [Abstract][Full Text] [Related]
27. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
29. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
30. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
[TBL] [Abstract][Full Text] [Related]
31. Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins.
Magee MJ; Salindri AD; Kornfeld H; Singhal A
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30523163
[No Abstract] [Full Text] [Related]
32. The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.
Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
Cell Cycle; 2009 Jan; 8(1):88-96. PubMed ID: 19106626
[TBL] [Abstract][Full Text] [Related]
33. Is There a Role for Statins and Metformin in Cancer Therapy?
Hassanabad AF
Am J Clin Oncol; 2020 Dec; 43(12):833-835. PubMed ID: 32910022
[No Abstract] [Full Text] [Related]
34. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
[TBL] [Abstract][Full Text] [Related]
35. Beta-blockers and diabetes: the bad guys come good.
Cruickshank JM
Cardiovasc Drugs Ther; 2002 Sep; 16(5):457-70. PubMed ID: 12652116
[TBL] [Abstract][Full Text] [Related]
36. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
Wysocki PJ; Wierusz-Wysocka B
Expert Rev Mol Diagn; 2010 May; 10(4):509-19. PubMed ID: 20465505
[TBL] [Abstract][Full Text] [Related]
37. Obesity and cancer: mechanistic insights from transdisciplinary studies.
Allott EH; Hursting SD
Endocr Relat Cancer; 2015 Dec; 22(6):R365-86. PubMed ID: 26373570
[TBL] [Abstract][Full Text] [Related]
38. Statins: a repurposed drug to fight cancer.
Jiang W; Hu JW; He XR; Jin WL; He XY
J Exp Clin Cancer Res; 2021 Jul; 40(1):241. PubMed ID: 34303383
[TBL] [Abstract][Full Text] [Related]
39. The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
Pharmacoeconomics; 2009; 27(3):221-30. PubMed ID: 19354342
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin Plus Metformin Confer Additive Benefits on Subjects with Dyslipidemia and Overweight/Obese via Reducing ROCK2 Concentration.
Hao Z; Liu Y; Liao H; Zheng D; Xiao C; Li G
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):246-50. PubMed ID: 27123784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
